Insider · CIK 0001602074
Sam Lee
Files at COCP (Cocrystal Pharma, Inc.). First filing -, latest -.
In brief
Sam Lee files SEC Form 4 as CEO and president at COCP (Cocrystal Pharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sam Lee has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | COCP Cocrystal Pharma, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +49,229 | $0.00 | $0 | 49,229 | Jan 13, 2026 |
| Oct 9, 2024 | COCP Cocrystal Pharma, Inc. | AGrant or award Common Stock | +40,000 | - | - | 76,355 | Oct 11, 2024 |
Questions about Sam Lee
Answered from the filings on this page, as of the latest one.
Is Sam Lee buying or selling?
Sam Lee has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sam Lee's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sam Lee has 0.
Where does Sam Lee file Form 4?
Sam Lee has filed Form 4 at COCP (Cocrystal Pharma, Inc.) as President and Co-CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.